YW MEMS completes PreA-1 round of multi-million yuan financing

On March 23, YW MEMS, an industry-leading independent research and development start-up company for bio-microelectromechanical (MEMS) chips, announced the completion of an angel round of financing of millions of yuan, invested by well-known domestic angel investors. After the completion of this round of financing, In-Situ Chips will focus on the emerging bio-MEMS chip market with strong independent R&D and production capabilities of chip technology. It will release the first domestic MEMS liquid flow sensor in 2018, and complete MEMS chip insulin pumps and POCT instant The development and pilot test of a number of promising new biochips such as blood test chips.

Biological MEMS chip-black technology combining semiconductor chip and biotechnology:

The biochip produced by the combination of semiconductor microelectromechanical (MEMS) chip technology and biomedical technology is an emerging technology that has only recently begun to be studied in the United States and Europe. At present, many companies in the United States and Europe have invested a lot of R&D resources in this field. The Swiss Debiotech company and STMicroelectronics has co-developed chip-type insulin pumps, and Abbott and Google also have a number of disruptive biochip blood test projects under development.

The silicon-based biochip is arranged with micron-scale mechanical structures and detection agents, and the structure size is smaller than a hair. It can make medical equipment and detection equipment chip, miniaturized, and instant, with improved performance and extremely low cost , Which will change the pattern of existing medical equipment, is a trillion-level blue ocean market for China's semiconductor and medical equipment to achieve corner overtaking.

In-situ chip company CEO Ma Shuo said: "With bio-MEMS technology, there will be several hundred yuan chip insulin pumps within 5 years. In addition, multiple desktop medical testing equipment will be chipped, blood tests no longer need to go to the hospital, and patients are at home. Put a drop of finger blood on the disposable chip, and you can enjoy an instant blood test and get dozens of biochemical indicators in 5 minutes."

The country's 20-year scientific research investment layout, my country also has independent property rights biological MEMS chips:

Biological MEMS chip involves the in-depth integration of two difficult technologies, semiconductor MEMS technology and biotechnology, and domestic industrialized products have been blank. However, the Ministry of Science and Technology of my country has made arrangements for more than 20 years in advance in the academic field, supported the research of multiple scientific research projects, and planted the fire for my country's independent innovation of biological MEMS chips.

The core team of in-situ chips originated from the Institute of Microelectronics of Tsinghua University and the Suzhou Institute of Nanotechnology, Chinese Academy of Sciences. The founder Ma Shuo completed a number of US and European monopoly bio-MEMS chip projects based on the technology accumulation of the research group during his graduate studies in 2011. the study. After completing the scientific research project in 2015, witnessing the monopoly of imported chips and the backwardness of the domestic bio-MEMS chip field, the in-situ chip team went to Suzhou to establish a company. Relying on the high-quality entrepreneurial environment of Suzhou Industrial Park and the complete MEMS industry chain resources, it began the difficult domestic biotechnology Chip industrialization innovation and entrepreneurship.

With years of accumulation of biological MEMS chip technology, the company has made rapid progress in the field of difficult biological MEMS chips. It has developed insulin pumps, instant blood test chips, silicon nitride thin film chips and in-situ chips to break foreign monopoly biochips. On this high-threshold race track, the company's technology accumulation, R&D team strength, industrial chain resources and patent accumulation have been in a leading position in China, and it has the ability to overtake the United States and Europe on corners.

According to the in-situ chip company, the completion of this round of financing is only the first step for the company to accelerate its development. In the future, the company will continue to cooperate with high-quality capital. The goal is to combine semiconductor technology with biotechnology, and use biochips to improve personal medical care. A leading company in the billion-level blue ocean biochip market.

The technical team and capital work together, and domestic capital is paying more and more attention to hard core technology innovation:

Making hard-core scientific and technological innovation products is a key shortcoming of China's industrial structure, as well as a difficulty in transformation. European and American countries focus on blocking my country's acquisition of hard technology companies, and the only way to industrial transformation is independent research and development. Ma Shuo compares the research and development of independent intellectual property rights of hard-core technology to climbing a 1,000-meter mountain: “The early research and development of the first 300 meters requires the cultivation of national scientific research funds and the support of the research team, and the mass production of products in the latter 300 meters can rely on strategic investment and bank loans. , And the mid-400-meter pilot test stage is the most difficult. Capital investment at this stage can only rely on the assistance of venture capital funds, and it is also the stage with the highest return on investment. It requires venture capitalists to have strong team analysis capabilities and compete against competition. Tao’s understanding and belief in technological innovation."

The gratifying thing is that at present, domestic early-stage funds have become more aware of the steady development characteristics and huge potential of hard core technology innovation and entrepreneurship, and many funds are transforming in this direction. Recently, many institutions announced the establishment of sub-funds focusing on hard technology innovation. According to the current competitive situation in the field of technological innovation between China and the United States, these hard technology investment funds will play an extremely important role in the development and industrialization of high-tech products in my country.